AAAAAA

   
Results: 1-10 |
Results: 10
CHARACTERIZATION OF THE SELECTIVITY AND MECHANISM OF HUMAN CYTOCHROME-P450 INHIBITION BY THE HUMAN IMMUNODEFICIENCY VIRUS-PROTEASE INHIBITOR NELFINAVIR MESYLATE
Authors: LILLIBRIDGE JH LIANG BH KERR BM WEBBER S QUART B SHETTY BV LEE CA
Citation: Jh. Lillibridge et al., CHARACTERIZATION OF THE SELECTIVITY AND MECHANISM OF HUMAN CYTOCHROME-P450 INHIBITION BY THE HUMAN IMMUNODEFICIENCY VIRUS-PROTEASE INHIBITOR NELFINAVIR MESYLATE, Drug metabolism and disposition, 26(7), 1998, pp. 609-616
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF NELFINAVIR, A NOVEL HIV-1 PROTEASE INHIBITOR, IN HUMAN PLASMA
Authors: WU EY WILKINSON JM NARET DG DANIELS VL WILLIAMS LJ KHALIL DA SHETTY BV
Citation: Ey. Wu et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF NELFINAVIR, A NOVEL HIV-1 PROTEASE INHIBITOR, IN HUMAN PLASMA, Journal of chromatography B. Biomedical sciences and applications, 695(2), 1997, pp. 373-380
VIRACEPT (NELFINAVIR MESYLATE, AG1343) - A POTENT, ORALLY BIOAVAILABLE INHIBITOR OF HIV-1 PROTEASE
Authors: KALDOR SW KALISH VJ DAVIES JF SHETTY BV FRITZ JE APPELT K BURGESS JA CAMPANALE KM CHIRGADZE NY CLAWSON DK DRESSMAN BA HATCH SD KHALIL DA KOSA MB LUBBEHUSEN PP MUESING MA PATICK AK REICH SH SU KS TATLOCK JH
Citation: Sw. Kaldor et al., VIRACEPT (NELFINAVIR MESYLATE, AG1343) - A POTENT, ORALLY BIOAVAILABLE INHIBITOR OF HIV-1 PROTEASE, Journal of medicinal chemistry, 40(24), 1997, pp. 3979-3985
THE PHARMACOKINETICS (PK) OF NELFINAVIR(N) ADMINISTERED ALONE AND WITH RIFAMPIN (RIF) IN HEALTHY-VOLUNTEERS
Authors: YUEN GJ ANDERSON R SANDOVAL T WU E SHETTY BV KERR BM
Citation: Gj. Yuen et al., THE PHARMACOKINETICS (PK) OF NELFINAVIR(N) ADMINISTERED ALONE AND WITH RIFAMPIN (RIF) IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 40-40
THE PHARMACOKINETICS (PK) OF NELFINAVIR(N) ADMINISTERED ALONE AND WITH KETOCONAZOLE(K) IN HEALTHY-VOLUNTEERS
Authors: KERR BM YUEN GJ SANDOVAL T WU E SHETTY BV ANDERSON R
Citation: Bm. Kerr et al., THE PHARMACOKINETICS (PK) OF NELFINAVIR(N) ADMINISTERED ALONE AND WITH KETOCONAZOLE(K) IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 42-42
AG337, A NOVEL LIPOPHILIC THYMIDYLATE SYNTHASE INHIBITOR - IN-VITRO AND IN-VIVO PRECLINICAL STUDIES
Authors: WEBBER S BARTLETT CA BORITZKI TJ HILLIARD JA HOWLAND EF JOHNSTON AL KOSA M MARGOSIAK SA MORSE CA SHETTY BV
Citation: S. Webber et al., AG337, A NOVEL LIPOPHILIC THYMIDYLATE SYNTHASE INHIBITOR - IN-VITRO AND IN-VIVO PRECLINICAL STUDIES, Cancer chemotherapy and pharmacology, 37(6), 1996, pp. 509-517
PRECLINICAL PHARMACOKINETICS AND DISTRIBUTION TO TISSUE OF AG1343, ANINHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE
Authors: SHETTY BV KOSA MB KHALIL DA WEBBER S
Citation: Bv. Shetty et al., PRECLINICAL PHARMACOKINETICS AND DISTRIBUTION TO TISSUE OF AG1343, ANINHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 110-114
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF A NOVEL THYMIDYLATE SYNTHASE INHIBITOR, AG-331, IN HUMAN SERUM
Authors: LI WY CHATTERJEE DJ SHETTY BV WU EY MUGGIA F KODA RT
Citation: Wy. Li et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF A NOVEL THYMIDYLATE SYNTHASE INHIBITOR, AG-331, IN HUMAN SERUM, Journal of chromatography B. Biomedical applications, 673(2), 1995, pp. 281-288
EVALUATION OF HEPATIC-METABOLISM OF SALICYLIC-ACID IN PERFUSED-RAT-LIVER
Authors: SHETTY BV BADR M MELETHIL S
Citation: Bv. Shetty et al., EVALUATION OF HEPATIC-METABOLISM OF SALICYLIC-ACID IN PERFUSED-RAT-LIVER, Journal of pharmaceutical sciences, 83(4), 1994, pp. 607-608
A STABILITY-INDICATING ASSAY AND THE PREFORMULATION CHARACTERISTICS OF THE RADIOSENSITIZER, 1,2,4-BENZOTRIAZIN-3-AMINE 1,4-DIOXIDE
Authors: RILEY CM SHETTY BV CHETWYN NC KASPER VT KINDBERG CG DICKEN CM
Citation: Cm. Riley et al., A STABILITY-INDICATING ASSAY AND THE PREFORMULATION CHARACTERISTICS OF THE RADIOSENSITIZER, 1,2,4-BENZOTRIAZIN-3-AMINE 1,4-DIOXIDE, Journal of pharmaceutical and biomedical analysis, 11(2), 1993, pp. 131-138
Risultati: 1-10 |